What is OrderlyMeds
Abbreviations DM2: diabetes mellitus type 2 GCR: glucagon receptor GIPR: glucose-dependent insulinotropic peptide receptor GLP-1a: glucagon-like peptide-1 analogues HbA1c: glycated hemoglobin HCC: hepatocellular carcinoma MRI-PDFF: Magnetic Resonance Imaging-Proton Density Fat Fraction NAFLD: Non-alcoholic fatty liver disease NASH: non-alcoholic steatohepatitis NCT: National Clinical Trial number PPAR: Peroxisome Proliferator-Activated Receptor RCT: randomized clinical trial SGLT-2i: sodium-glucose co-transporter-2 inhibitors Declarations Funding None to declare
GLP-1 (Glucagon-Like Peptide-1) receptor agonists are medications that mimic a naturally occurring gut hormone released after eating
Practical Dosing Implications: What Actually Works Let me give you the protocol framework Ive seen work consistently across diverse populations For acute injuries (muscle tears, sprains, tendon damage, etc.): 250-500 mcg subcutaneously, twice daily (morning and evening) Dosing directly near the injury site may provide additional local benefit Continue for 2-4 weeks or until substantial improvement For chronic conditions (gut issues, systemic inflammation, joint pain, etc.): 250-500 mcg subcutaneously, once daily Timing is flexible but consistency matters Many people run 4-8 week cycles with breaks For general recovery and tissue maintenance: 250 mcg once daily, 3-5 days per week Can be used post-workout or before bed What you DO NOT have to do is dose BPC-157 every 4-6 hours like some misinformed sources suggest
GLP-1 signals the brain that you are full, slows stomach emptying, prompts the pancreas to release insulin, and keeps the liver from dumping sugar into the bloodstream